Mark S. Levine - Jan 28, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Signature
/s/ Eva Renee Barnett, attorney-in-fact for Mark Levine
Stock symbol
IMVT
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 04:01 PM
Previous filing
Jan 28, 2022
Next filing
Aug 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +143K $0.00 143K Jan 28, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +383K $0.00 383K Jan 28, 2022 Common Stock 383K $6.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest over four years, with 25% of the RSUs vesting on January 19, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3 Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on January 19, 2023 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.